Information
X


Newsletters

Calbiochem Biologics
Biologics 35.1: Histone Acetylation and Deacetylation
Biologics 34.1: TGF-b signaling in Tumor Suppression and Oncogenesis
Biologics 33.2: PI 3-Kinase: A Multifunctional Signaling Molecule
Biologics 33.1: PARP in DNA Repair and Apoptosis
Biologics 32.4: Cancer Stem Cells: The Real Perpetrators in Cancer Growth and Progression
Biologics 32.3: NF-kB Activation: A Link Between Chronic Inflammation and Cancer
Biologics 32.2: Diabetes, Insulin Resistance, and the Metabolic Syndrome X
Biologics 32.1: Glycogen Synthase Kinase-3: Its Signaling Role in Development and Disease
Biologics 31.1: Akt/PI 3-Kinase Signaling in Cell Death & Cell Survival
Biologics 30.2: Tubulin Polymerization and Depolymerization: Exploiting the Dynamic Instability of Microtubules
Biologics 30.1: NF-KB - A Therapeutic Target for Inflammation and Cancer
Biologics 29.4: Cell Cycle Checkpoints: Molecular Targets for Cancer Chemotherapy
Biologics 29.3: Nuclear Import/Export: A Nuclear Revolving Door
Biologics 29.2: Defective Insulin Signaling in Diabetes
Biologics 29.1: Protein Tyrosine Kinases: Rational Targets for Cancer Therapy
Biologics 28.1: Alzheimer's Disease: Misguided Slicing of Amyloid Precursor Protein by Sectretases
Biologics 27.2: Apoptosis: Mitochondrial Intermembrane Proteins - The Beginner's of the End
Biologics 27.1: Oxidative Stress: A Causative Factor in the Pathogenesis of Alzheimer's Disease
Biologics 26.1: Tumor Metastasis: Role of Cell Adhesion and Matrix Metalloproteases
Novagen inNovations
inNovations 29, September 2008
inNovations 28, July 2008
inNovations 27, March 2008
inNovations 26, September 2007
inNovations 25, February 2007
inNovations 24, August 2006
inNovations 23, May 2006
inNovations 22, November 2005
inNovations 21, July 2005
inNovations 20, October 2004
inNovations 19, April 2004
inNovations 18, October 2003
inNovations 17, June 2003
inNovations 16, March 2003
inNovations 15, November 2002
inNovations 14, July 2002
inNovations 13, November 2001
inNovations 12, June 2001
inNovations 11, June 2000
inNovations 10, November 1999
inNovations 9, January 1999
inNovations 8, September 1998
inNovations 7, August 1997
inNovations 6, December 1996
inNovations 5, August 1996
inNovations 4, May 1996
inNovations 3, June 1995
inNovations 2, November 1994
inNovations 1, May 1994
Novabiochem Innovations
Innovations 01/10: Total synthesis of the 101 residue d2 domain of VEGF receptor 1
Innovations 02/09: Non-explosive replacement for HOBt
Innovations 01/09: Synthesis of FBP28WW domains using pseudoproline and isoacyl dipeptides
Innovations 02/08: Synthesis of β-amyloid using an isoacyl dipeptide
Innovations 01/08: Overcoming aspartimide formation in Fmoc SPPS
Innovations 04/07: Comparison of pseudoproline and isoacyl dipeptides in the synthesis of difficult sequences
Innovations 03/07: Synthesis of the transmembrane region of bradykinin receptor
Innovations 02/07: Synthesis of peptides containing methylated lysine residues
Innovations 01/07: Synthesis of wild-type and phosphorylated phospholamban
Innovations 06/06: Smart peptide synthesis: Synthesis of the Rantes
Innovations 05/06: Synthesis of peptides containing methylated arginine residues
Innovations 04/06: Synthesis of PADRE-Muc chimeric peptide
Innovations 03/06: Synthesis of neurotoxic prion peptide (106 - 126)
Innovations 02/06: The role of HOBt in coupling reactions
Innovations 01/06: Synthesis of highly amyloidogenic human IAPP using pseudoproline dipeptides
Innovations 06/05: Solid phase synthesis of AMC-based enzyme substrates
Innovations 05/05: Expediting convergent synthesis with pseudoproline dipeptides
Innovations 04/05: New tools for SPPS of labeled peptides
Innovations 03/05: Synthesis of highly amyloidogenic human IAPP using pseudoproline dipeptides
Innovations 02/05: SPPS of biotinylated peptides
Innovations 01/05: New tools for the SPPS of FRET peptides
Innovations 06/04: Epimerization-free fragment condensation with pseudoproline (oxazolidine) dipeptides
Innovations 05/04: Strategies for the synthesis of peptide aldehydes
Innovations 04/04: Exploring Strategies for Peptide Synthesis
Innovations 03/04: Synthesis design using pseudoproline dipeptides
Innovations 02/04: Microwave accelerated Suzuki couplings employing a polymer-supported palladium phosphine
Innovations 01/04: Guidelines for the use of Pseudoproline Dipeptides
Innovations 04/03: Stability of polymer-supports to microwave heating
Innovations 03/03: IBX Polystyrene
Innovations 02/03: Synthesis of long peptides using pseudoproline dipeptides
Innovations 01/03: New derivatives for overcoming aspartimide formation
Innovations 04/02: Optimized coupling procedures for unusual amino acids
Novabiochem Letters
Letters 01/10: New reagents for click ligation reactions
Letters 02/09: Resins for the synthesis of thioesters by Fmoc SPPS
Letters 01/09: Non-explosive replacement for HOBt
Letters 02/08: New PEG-based resins for smart peptide synthesis
Letters 01/08: New Derivative for the introduction of symmetrical dimethylated arginine
Letters 02/07: Derivatives for enhancing peptide synthesis
Letters 01/07: Derivatives for enhancing peptide synthesis
Letters 04/06: Reagents for the synthesis of cyclic and modified peptides
Letters 03/06: New reagents for peptide synthesis
Letters 02/06: New resins for peptide synthesis
Letters 01/06: Reagents for peptide synthesis
Letters 04/05: New products for peptide synthesis
Letters 03/05: New products for peptide synthesis
Letters 02/05: New products for biomolecule labeling
Letters 01/05: Fmoc amino acids
Letters 04/04: PEG reagents
Letters 03/04: Amino acids for Fmoc SPPS
Letters 02/04: Products for peptide ligation
Letters 01/04: Resins for the synthesis of biotinylated and fluorescently-labeled peptides
Letters 02/03: New solubilizing biotinylating reagent
Letters 01/03: Fluorescent dyes
Letters 03/02: Coupling reagent
Letters 02/02: Derivatives for overcoming aspartimide formation
Letters 01/02: Amino acid derivatives
Letters 04/01: Derivatives for chemoselective ligation
Letters 03/01: Fluorescent-labelled amino acid derivative
Letters 02/01: Selectively protected amino acids for the synthesis of cyclic and branched peptides
Letters 01/01: Derivatives for the introduction of selenocysteine
Letters 02/00: Amino acid derivatives for phosphopeptide synthesis
Letters 01/00: Resins for solid phase organic synthesis
WideScreen Newsletters
WideScreen™ Spring 2010 Newsletter

© Merck KGaA, Darmstadt, Germany, 2013

All references to Merck refer to Merck KGaA, Darmstadt, Germany.


x

Welcome to EMD Millipore

 

Europe, Middle East and Africa Asia / Pacific North America, Central America and the Carribean South America

Please select your country:

North America, Central America and the Carribean


South America


Europe, Middle East and Africa


Asia / Pacific


All countries from A to Z


If you can't find your country please click here.

 

x

EMD Millipore Chemicals Cart ()

You are entering the Millipore online shop. Both carts are maintained for you while you shop between sites. We recommend to complete your Merck order before visiting Millipore.com.

Go to Millipore Proceed to checkout


What kind of products are you looking for?

Millipore

Bio manufacturing and Life science.

EMD Millipore Chemicals

High-quality industrial and laboratory chemicals.

Important message

It is currently not possible to order Bioscience products together with other EMD products. We recommend completing your current order first.

Do you wish to proceed without completing your current order? If so, this will empty your shopping cart.